Knight Therapeutics (GUD) Insider Trading & Ownership C$5.87 +0.02 (+0.34%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock Knight Therapeutics (TSE:GUD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage45.62%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$663.16KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)C$19.73M Get GUD Insider Trade Alerts Want to know when executives and insiders are buying or selling Knight Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GUD Insider Buying and Selling by Quarter Knight Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/21/2025Sime ArmoyanInsiderSell2,500,000C$6.30C$15,750,000.003/19/2025Sime ArmoyanInsiderSell550,000C$6.20C$3,410,000.003/17/2025Sime ArmoyanInsiderSell92,200C$6.15C$567,030.003/13/2025Sime ArmoyanInsiderSell1,100C$6.10C$6,710.003/4/2025Sime ArmoyanInsiderBuy17,600C$5.48C$96,488.4811/12/2024Sime ArmoyanInsiderBuy90,300C$5.13C$463,672.4411/11/2024Samira SakhiaDirectorBuy20,000C$5.15C$103,000.00 (Data available from 1/1/2013 forward) GUD Insider Trading Activity - Frequently Asked Questions Who is on Knight Therapeutics' Insider Roster? The list of insiders at Knight Therapeutics includes Amal Khouri, Jonathan Ross Goodman, Robert Nathaniel Lande, Samira Sakhia, and Sime Armoyan. Learn more on insiders at GUD. What percentage of Knight Therapeutics stock is owned by insiders? 45.62% of Knight Therapeutics stock is owned by insiders. Learn more on GUD's insider holdings. Which Knight Therapeutics insiders have been buying company stock? The following insiders have purchased GUD shares in the last 24 months: Jonathan Ross Goodman (C$29,000.00), Samira Sakhia (C$103,000.00), and Sime Armoyan (C$2,440,245.92). How much insider buying is happening at Knight Therapeutics? Insiders have purchased a total of 491,200 GUD shares in the last 24 months for a total of C$2,572,245.92 bought. Which Knight Therapeutics insiders have been selling company stock? The following insiders have sold GUD shares in the last 24 months: Amal Khouri (C$290,766.00), Robert Nathaniel Lande (C$207,310.50), and Sime Armoyan (C$22,412,245.00). How much insider selling is happening at Knight Therapeutics? Insiders have sold a total of 3,673,900 Knight Therapeutics shares in the last 24 months for a total of C$22,910,321.50 sold. Knight Therapeutics Key ExecutivesMr. Jonathan Ross Goodman B.A. (Age 55)L.L.B., M.B.A., Executive Chairman Compensation: $250.94kMs. Samira Sakhia BCom (Age 56)CA, CPA, MBA, President, CEO & Director Compensation: $674.28kMr. Arvind UtchanahChief Financial OfficerMs. Amal Khouri B.Sc.M.B.A., Chief Business OfficerMr. Jeff MartensGlobal Vice President of CommercialMr. Stephani SaverioVice President of Business DevelopmentMr. Leopoldo BosanoVice-President of Manufacturing & OperationsMs. Monica PercarioGlobal Vice President of Scientific AffairsMr. Henrique DiasGlobal Director of MarketingMs. Susan Caroline EmblemGlobal Vice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies WEED Insider Trades ACB Insider Trades CPH Insider Trades OGI Insider Trades HLS Insider Trades RX Insider Trades CRDL Insider Trades MDP Insider Trades DB Insider Trades WLLW Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (TSE:GUD) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersTesla’s $30 trillion pivotCircle Nov 6 – huge Tesla news? Tesla could be about to change forever. On November 6, insiders are warning...Altimetry | SponsoredBitcoin at $125,000 is fantastic news… for this coinAs Bitcoin surges past $125,000, one under-the-radar altcoin — faster, cheaper, and already backed by major in...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
